Subpart A
GENETIC CONDITIONS AND NEWBORNS
Sections
- § 40:1081.1 Programs for combating phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, biotinidase deficiency, and other genetic conditions active
- § 40:1081.2 Tests active
- § 40:1081.3 Cooperation with the Louisiana Department of Health active
- § 40:1081.4 Cooperation of physicians and hospitals active
- § 40:1081.5 Redesignated as R.S. 40:1125.31 by Acts 2022, No. 647, §4C. active
- § 40:1081.6 Redesignated as R.S. 40:1125.32 by Acts 2022, No. 647, §4C. active
- § 40:1081.7 Redesignated as R.S. 40:1125.33 by Acts 2022, No. 647, §4C. active
- § 40:1081.8 Redesignated as R.S. 40:1125.21 by Acts 2022, No. 647, §4B. active
- § 40:1081.9 Hemophilia; state treatment program; advisory committee active
- § 40:1081.10 Privacy of genetic information active
- § 40:1081.11 Krabbe disease; public information active
- § 40:1081.12 Medicaid coverage; genetic testing of critically ill infants active
- § 40:1081.13 Medicaid coverage; amino acid-based elemental formulas active